X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.prnewswire.com/news-releases/bluerocks-phase-i-study-with-bemdaneprocel-in-patients-with-parkinsons-disease-meets-primary-endpoint-301910863.html
https://www.prnewswire.com/news-releases/novel-combination-of-oral-ketamine-and-aspirin-is-safe-form-of-pain-medication-after-total-knee-replacement-surgery-301902136.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/now-you-will-need-a-prescription-for-buying-aspirin-ibrufin-diclofinac-in-delhi-read-why/articleshow/102003935.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://recalls-rappels.canada.ca/en/alert-recall/jamp-asa-ec-product-quality
https://www.prnewswire.com/news-releases/new-voyager-pad-analysis-confirms-consistent-benefit-of-xarelto-rivaroxaban-plus-aspirin-following-lower-extremity-revascularization-ler-301762498.html
https://www.fiercepharma.com/marketing/plx-pharma-strikes-new-collab-baseball-legend-john-smoltz-take-its-pain-drug-vazalore
https://www.escardio.org/The-ESC/Press-Office/Press-releases/COVID-19-patients-in-the-community-do-not-benefit-from-colchicine-or-aspirin
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-27-2022-1659339221.pdf
https://www.prnewswire.com/news-releases/new-data-from-two-large-studies-reinforce-effectiveness-of-dual-pathway-inhibition-dpi-with-xarelto-rivaroxaban-plus-aspirin-in-patients-with-coronary-artery-disease-cad-andor-peripheral-artery-disease-pad-301552796.html
https://www.prnewswire.com/news-releases/data-from-new-voyager-pad-analyses-at-acc22-reinforce-benefit-of-xarelto-rivaroxaban-plus-aspirin-in-patients-with-peripheral-artery-disease-pad-and-various-co-morbid-conditions-301515529.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-9-2022-1644385243.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211695
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-26-2022-1643358623.pdf
https://www.fiercebiotech.com/biotech/jpm-2022-bayer-s-research-head-looks-to-reinvent-r-d-as-pharma-innovates-biotech
https://newsroom.heart.org/news/long-term-low-dose-aspirin-did-not-affect-risk-of-dementia-in-adults-with-type-2-diabetes
https://www.globenewswire.com/news-release/2021/11/04/2327725/37097/en/PLx-Pharma-Inc-Announces-New-Scientific-Data-Available-Evaluating-the-Pharmacologic-Profile-of-FDA-Approved-VAZALORE-81-mg-Liquid-Filled-Aspirin-Capsules.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205230
https://www.globenewswire.com/news-release/2021/10/14/2314570/37097/en/PLx-Pharma-Inc-Issues-Statement-on-Recent-USPTF-Recommendations-on-Aspirin-Therapy-for-Primary-Prevention-of-Cardiovascular-Disease-PLx-s-VAZALORE-Specifically-Indicated-for-Second.html
http://www.pharmabiz.com/NewsDetails.aspx?aid=143242&sid=2
Market Place
Share 
